Navios Maritime (NMM) is rated Buy due to its strong earnings, organic growth, and a significant 56% discount to net asset value (NAV). The company operates a diversified fleet of 149 vessels across dry bulk, containerships, and tankers, maintaining low operating expenses and high utilization rates. Its operating cash flows support fleet expansion and debt repayment, enabling sustainable growth without diluting shares. With $410 million in cash, Navios has strategic flexibility to address its aging fleet and capitalize on market improvements, presenting substantial upside potential for investors.
Levi & Korsinsky has started an investigation into Regeneron Pharmaceuticals for potentially misleading investors about the results of a clinical trial. In March 2026, Regeneron's investor relations VP expressed hope for positive trial outcomes of a ...
Levi & Korsinsky has started an investigation into Prestige Consumer Healthcare following the company's failure to meet its Q4 and full-year financial projections, including adjusted gross margin, free cash flow, and adjusted EPS. Additionally, Prest...
Levi & Korsinsky has started an investigation into TriSalus Life Sciences following the company's Q1 2026 revenue of $8.9 million, which missed Wall Street's $9.4 million estimate. The company also lowered its full-year 2026 revenue forecast to $54 m...
Bitcoin whale traders have shifted aggressively toward short positions, reflecting growing defensive sentiment amid weakening broader crypto momentum. Large speculative wallets reduced altcoin exposure and increased leveraged Bitcoin shorts, with one...
Figma has achieved a 46% year-over-year revenue growth and improved its net dollar retention to 139%, showing resilience against fears of AI disruption. The company is transitioning to a usage-based pricing model and benefiting from AI trends, which ...
